Showing results (281-290 of 291) with videos related to
Sort By:
Pageof 30
Vaccine|June 1, 1997
Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trialK E Ugen, J D Boyer, B Wang, et al.Nature Communications|July 23, 2014
Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosisK Sugihara, Y Kobayashi, A Suzuki, et al.Nature Medicine|May 1, 1997
Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccinationJ D Boyer, K E Ugen, B Wang, et al.International Quarterly of Community Health Education|September 16, 2010
A program to reduce cardiovascular and cerebrovascular disease in the czech republic: design and methods of the healthy dubec projectC L Albright, J W Farquhar, R Havel, et al.Journal of Virology|July 11, 1996
Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1R Shibata, C Siemon, M W Cho, et al.Journal of the American Academy of Dermatology|July 25, 2000
Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?G G Krueger, S R Feldman, C Camisa, et al.Proceedings of the National Academy of Sciences of the United States of America|August 16, 2001
An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- miceK Podsypanina, R T Lee, C Politis, et al.Archives of Internal Medicine|April 29, 1998
Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research GroupP J Savage, S L Pressel, J D Curb, et al.Placenta|July 28, 2009
Feto-placental adaptations to maternal obesity in the baboonD Farley, M E Tejero, A G Comuzzie, et al.Journal of the American Academy of Dermatology|June 19, 1998
Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenailM R Ling, L J Swinyer, M T Jarratt, et al.Pageof 30